Antigen‐specific immunotherapy of cervical and ovarian cancer
We contrast the efforts to treat ovarian cancer and cervical cancer through vaccination
because of their different pathobiology. A plethora of approaches have been developed for …
because of their different pathobiology. A plethora of approaches have been developed for …
Therapeutic human papillomavirus vaccines: current clinical trials and future directions
Background: Cervical cancer is the second largest cause of cancer deaths in women
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …
Nanog signaling in cancer promotes stem-like phenotype and immune evasion
KH Noh, BW Kim, KH Song, H Cho… - The Journal of …, 2012 - Am Soc Clin Investig
Adaptation of tumor cells to the host is a major cause of cancer progression, failure of
therapy, and ultimately death. Immune selection drives this adaptation in human cancer by …
therapy, and ultimately death. Immune selection drives this adaptation in human cancer by …
Perspectives for preventive and therapeutic HPV vaccines
Human Papillomavirus (HPV) has been associated with several human cancers, including
cervical cancer, vulvar cancer, vaginal and anal cancer, and a subset of head and neck …
cervical cancer, vulvar cancer, vaginal and anal cancer, and a subset of head and neck …
Therapeutic hpv DNA vaccines
It is now well established that most cervical cancers are causally associated with HPV
infection. This realization has led to efforts to control HPV-associated malignancy through …
infection. This realization has led to efforts to control HPV-associated malignancy through …
Immunotherapy for cervical cancer: Research status and clinical potential
The high-risk types of human papillomavirus (HPV) have been found to be associated with
most cervical cancers and play an essential role in the pathogenesis of the disease. Despite …
most cervical cancers and play an essential role in the pathogenesis of the disease. Despite …
Therapeutic DNA vaccines for human papillomavirus and associated diseases
Human papillomavirus (HPV) has long been recognized as the causative agent of cervical
cancer. High-risk HPV types 16 and 18 alone are responsible for over 70% of all cases of …
cancer. High-risk HPV types 16 and 18 alone are responsible for over 70% of all cases of …
Targeted treatments for cervical cancer: a review
O Peralta-Zaragoza, VH Bermúdez-Morales… - OncoTargets and …, 2012 - Taylor & Francis
Cervical cancer is the second most common cause of cancer death in women worldwide
and the development of new diagnosis, prognostic, and treatment strategies merits special …
and the development of new diagnosis, prognostic, and treatment strategies merits special …
Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model
CT Nguyen, SH Hong, JI Sin, HVD Vu, K Jeong… - Vaccine, 2013 - Elsevier
Tumor antigen (TA)-specific immunotherapy is an emerging approach for cancer treatment.
Potent adjuvants are prerequisites to the immunotherapy for overcoming the low …
Potent adjuvants are prerequisites to the immunotherapy for overcoming the low …
Antigen‐specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis
WE Purtha, N Myers, V Mitaksov, E Sitati… - European journal of …, 2007 - Wiley Online Library
Abstract Infection with West Nile virus (WNV) causes fatal encephalitis in
immunocompromised animals. Previous studies in mice have established that T cell …
immunocompromised animals. Previous studies in mice have established that T cell …